Moderna cuts 2025 sales forecast by $1B on weak vaccine demand

Posted on January 13, 2025

Moderna cut its 2025 sales forecast by $1 billion today, hurt by a slow adoption of its respiratory syncytial virus (RSV) shot and weak demand for COVID-19 vaccines, sending its shares down more than 18% in premarket trading.

See the original article at: Honolulu Star-Advertiser

<--- Like this post? You know what to do.

Comments are closed.